Work

Abstract CT190: Brexu-cel + dasatinib: Safety and feasibility of dasatinib pulses after brexucabtagene autoleucel to modulate CAR T cell activity in relapsed/refractory B cell acute lymphoblastic leukemia

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct190

Authors: Nikeshan Jeyakumar, Parveen Shiraz, Evan Weber, Alyssa Kanegai, Caroline Wagner, Arvind Ramakrishnan, Bita Sahaf, Matthew Frank, Saurabh Dahiya, Melody Smith, Surbhi Sidana, Crystal Mackall, David Miklos, Lori Muffly

Institutions: University of California, Los Angeles, Stanford University, Children's Hospital of Philadelphia

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154705102

Cites:

Cited by:

Related to: